Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,431
archived clinical trials in
Back Pain

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
1952
mi
from 43215
Incline Village, NV
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
1952
mi
from 43215
Incline Village, NV
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
1330
mi
from 43215
Albuquerque, NM
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
1330
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
358
mi
from 43215
Rochester, NY
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
358
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
302
mi
from 43215
Asheville, NC
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
302
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
106
mi
from 43215
Akron, OH
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
106
mi
from 43215
Akron, OH
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
853
mi
from 43215
Norman, OK
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
853
mi
from 43215
Norman, OK
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
162
mi
from 43215
Pittsburgh, PA
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
617
mi
from 43215
Cranston, RI
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
617
mi
from 43215
Cranston, RI
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
376
mi
from 43215
Anderson, SC
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
376
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
995
mi
from 43215
Houston, TX
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Trial of Scrambler Therapy or Sham Treatment for Low Back Pain
A Pilot Randomized Trial of Scrambler Therapy or Sham Treatment for Persistent Nonspecific Low Back Pain
Status: Enrolling
Updated:  7/10/2013
Virginia Commonwealth University School of Nursing
344
mi
from 43215
Richmond, VA
Trial of Scrambler Therapy or Sham Treatment for Low Back Pain
A Pilot Randomized Trial of Scrambler Therapy or Sham Treatment for Persistent Nonspecific Low Back Pain
Status: Enrolling
Updated: 7/10/2013
Virginia Commonwealth University School of Nursing
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Comparison of Extensible and Inextensible Lumbosacral Orthoses for Lower Back Pain
Comparison of Inextensible and Extensible Lumbosacral Orthoses for the Management of Episodes of Lower Back Pain
Status: Enrolling
Updated:  8/28/2013
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Comparison of Extensible and Inextensible Lumbosacral Orthoses for Lower Back Pain
Comparison of Inextensible and Extensible Lumbosacral Orthoses for the Management of Episodes of Lower Back Pain
Status: Enrolling
Updated: 8/28/2013
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated:  8/30/2013
Drexel University
416
mi
from 43215
Phildadelphia, PA
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated: 8/30/2013
Drexel University
416
mi
from 43215
Phildadelphia, PA
Click here to add this to my saved trials
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated:  8/30/2013
Optimum Physical Therapy Associates
393
mi
from 43215
West Chester, PA
Clinical Prediction Rule for Clinical Lumbar Instability
Identifying the Subgroup of Patient With Mechanical Low Back Pain Who Have Clinical Lumbar Instability
Status: Enrolling
Updated: 8/30/2013
Optimum Physical Therapy Associates
393
mi
from 43215
West Chester, PA
Click here to add this to my saved trials
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients
Status: Enrolling
Updated:  8/30/2013
UB/MD Family Medicine, Inc.
301
mi
from 43215
Amherst, NY
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients
Status: Enrolling
Updated: 8/30/2013
UB/MD Family Medicine, Inc.
301
mi
from 43215
Amherst, NY
Click here to add this to my saved trials
Sub-Sensory Intraspinal Neurostimulation Therapy
Sub-Sensory Intraspinal Neurostimulation Therapy In the Treatment of Neuropathic Back and/or Leg Pain
Status: Enrolling
Updated:  10/30/2013
Comprehensive Pain & Rehabilitation
732
mi
from 43215
Pascagoula, MS
Sub-Sensory Intraspinal Neurostimulation Therapy
Sub-Sensory Intraspinal Neurostimulation Therapy In the Treatment of Neuropathic Back and/or Leg Pain
Status: Enrolling
Updated: 10/30/2013
Comprehensive Pain & Rehabilitation
732
mi
from 43215
Pascagoula, MS
Click here to add this to my saved trials
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated:  11/8/2013
Des Moines University
566
mi
from 43215
Des Moines, IA
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated: 11/8/2013
Des Moines University
566
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated:  11/8/2013
Walsh University
105
mi
from 43215
North Canton, OH
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated: 11/8/2013
Walsh University
105
mi
from 43215
North Canton, OH
Click here to add this to my saved trials
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated:  11/8/2013
Youngstown State University
147
mi
from 43215
Youngstown, OH
Prescriptive Mobilization Versus a Pragmatic Mobilization
The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial
Status: Enrolling
Updated: 11/8/2013
Youngstown State University
147
mi
from 43215
Youngstown, OH
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Desert Institute for Spine Care
1662
mi
from 43215
Phoenix, AZ
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Desert Institute for Spine Care
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
SpineCare Medical Group
2112
mi
from 43215
Daly City, CA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
SpineCare Medical Group
2112
mi
from 43215
Daly City, CA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Memorial Orthopedic Surgical Group
1977
mi
from 43215
Long Beach, CA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Memorial Orthopedic Surgical Group
1977
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
The Spine Institute
1985
mi
from 43215
Santa Monica, CA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
The Spine Institute
1985
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Pain Center Solutions
423
mi
from 43215
Marietta, GA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Pain Center Solutions
423
mi
from 43215
Marietta, GA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Indiana Spine Group
166
mi
from 43215
Carmel, IN
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Indiana Spine Group
166
mi
from 43215
Carmel, IN
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Maine Medical Partners
699
mi
from 43215
Scarborough, ME
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Maine Medical Partners
699
mi
from 43215
Scarborough, ME
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Partners in Research and Educational Studies of Spinal Disorders (PressD)
174
mi
from 43215
Southfield, MI
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Partners in Research and Educational Studies of Spinal Disorders (PressD)
174
mi
from 43215
Southfield, MI
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
OrthoCarolina
350
mi
from 43215
Charlotte, NC
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
OrthoCarolina
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
NeuroSpine Institute LLC
2055
mi
from 43215
Eugene, OR
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
NeuroSpine Institute LLC
2055
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Rothman Institute
416
mi
from 43215
Philadelphia, PA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Rothman Institute
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Seton Spine & Scoliosis Center
1062
mi
from 43215
Austin, TX
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Seton Spine & Scoliosis Center
1062
mi
from 43215
Austin, TX
Click here to add this to my saved trials
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated:  11/12/2013
Virginia iSpine Physicians
338
mi
from 43215
Richmond, VA
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Status: Enrolling
Updated: 11/12/2013
Virginia iSpine Physicians
338
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Study
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  11/13/2013
Palmer Center for Chiropractic Research
409
mi
from 43215
Davenport, IA
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Study
PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 11/13/2013
Palmer Center for Chiropractic Research
409
mi
from 43215
Davenport, IA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10416
462
mi
from 43215
Anniston, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10416
462
mi
from 43215
Anniston, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site
492
mi
from 43215
Birmingham, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10426
699
mi
from 43215
Mobile, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10426
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site
558
mi
from 43215
Montgomery, AL
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site
558
mi
from 43215
Montgomery, AL
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 34
1662
mi
from 43215
Phoenix, AZ
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 34
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10276
1641
mi
from 43215
Tucson, AZ
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10276
1641
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10358
1960
mi
from 43215
Anaheim, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10358
1960
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10408
2024
mi
from 43215
Bell Gardens, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10408
2024
mi
from 43215
Bell Gardens, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10425
2034
mi
from 43215
Carmichael, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10425
2034
mi
from 43215
Carmichael, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10390
1967
mi
from 43215
Cerritos, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10390
1967
mi
from 43215
Cerritos, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10429
mi
from 43215
El Cajon, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10429
mi
from 43215
El Cajon, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10423
1936
mi
from 43215
Escondido, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10423
1936
mi
from 43215
Escondido, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10740
1962
mi
from 43215
Garden Grove, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10740
1962
mi
from 43215
Garden Grove, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10391
1973
mi
from 43215
Huntington Park, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10391
1973
mi
from 43215
Huntington Park, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 04
1953
mi
from 43215
La Jolla, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 04
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10442
1969
mi
from 43215
Laguna Hill, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10442
1969
mi
from 43215
Laguna Hill, CA
Click here to add this to my saved trials
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated:  11/15/2013
Teva Investigational Site 10413
1955
mi
from 43215
Laguna Hills, CA
Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Status: Enrolling
Updated: 11/15/2013
Teva Investigational Site 10413
1955
mi
from 43215
Laguna Hills, CA
Click here to add this to my saved trials